Literature DB >> 6572957

Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.

J M Adams, S Gerondakis, E Webb, L M Corcoran, S Cory.   

Abstract

Molecular cloning has recently established that the 15;12 chromosome translocations in murine plasmacytomas fuse DNA from chromosome 15 to the immunoglobulin heavy (H) chain locus, usually within the switch recombination region near the alpha constant region gene. We show here that the incoming DNA bears the cellular gene (c-myc) homologous to the oncogene (v-myc) of avian retrovirus MC29. In human Burkitt lymphomas bearing an 8;14 translocation, c-myc was also rearranged, apparently (in at least two cases) to an H chain switch recombination region (mu or alpha), and both products of a reciprocal chromosome exchange were detectable. Both the murine and human c-myc genes contain two exons homologous to v-myc, and additional 5' and 3' murine genomic segments (apparent exons) were defined by hybridization to c-myc mRNAs. In plasmacytomas, chromosome breakpoints fall near or within the 5' exon and apparently disrupt the normal c-myc transcriptional unit, because plasmacytoma c-myc mRNAs differ from the mRNA in lines without c-myc rearrangement. The translocated gene presumably has lost its normal 5' regulatory sequences and may well encode an altered myc polypeptide. We propose that altered expression of the c-myc gene, induced by translocation to an immunoglobulin locus, is a critical oncogenic event for these B lymphoid tumors. Two events may be required, because the plasmacytoma oncogene capable of transforming fibroblasts is not c-myc.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572957      PMCID: PMC393736          DOI: 10.1073/pnas.80.7.1982

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Nucleotide sequence to the v-myc oncogene of avian retrovirus MC29.

Authors:  K Alitalo; J M Bishop; D H Smith; E Y Chen; W W Colby; A D Levinson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

Authors:  R Dalla-Favera; E P Gelmann; S Martinotti; G Franchini; T S Papas; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

3.  Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Authors:  G L Shen-Ong; E J Keath; S P Piccoli; M D Cole
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

4.  DNA sequence associated with chromosome translocations in mouse plasmacytomas.

Authors:  L J Harris; P D'Eustachio; F H Ruddle; K B Marcu
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors.

Authors:  J M Adams; S Gerondakis; E Webb; J Mitchell; O Bernard; S Cory
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

6.  Mouse c-myc oncogene is located on chromosome 15 and translocated to chromosome 12 in plasmacytomas.

Authors:  S Crews; R Barth; L Hood; J Prehn; K Calame
Journal:  Science       Date:  1982-12-24       Impact factor: 47.728

7.  Molecular cloning of translocations involving chromosome 15 and the immunoglobulin C alpha gene from chromosome 12 in two murine plasmacytomas.

Authors:  K Calame; S Kim; P Lalley; R Hill; M Davis; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells.

Authors:  R Dalla-Favera; M Bregni; J Erikson; D Patterson; R C Gallo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Authors:  R Taub; I Kirsch; C Morton; G Lenoir; D Swan; S Tronick; S Aaronson; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.

Authors:  K B Marcu; L J Harris; L W Stanton; J Erikson; R Watt; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  101 in total

1.  Poly(A) tail shortening is the translation-dependent step in c-myc mRNA degradation.

Authors:  I A Laird-Offringa; C L de Wit; P Elfferich; A J van der Eb
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

2.  Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA.

Authors:  I A Laird-Offringa; P Elfferich; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations.

Authors:  Davide F Robbiani; Anne Bothmer; Elsa Callen; Bernardo Reina-San-Martin; Yair Dorsett; Simone Difilippantonio; Daniel J Bolland; Hua Tang Chen; Anne E Corcoran; André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2008-12-12       Impact factor: 41.582

4.  The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus.

Authors:  J Erikson; J Finan; Y Tsujimoto; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia.

Authors:  K Ha; M Minden; N Hozumi; E W Gelfand
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

Review 7.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

8.  A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

Authors:  J Squire; B L Gallie; R A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

9.  Role of the translocation partner in protection against AID-dependent chromosomal translocations.

Authors:  Mila Jankovic; Davide F Robbiani; Yair Dorsett; Thomas Eisenreich; Yang Xu; Alexander Tarakhovsky; Andre Nussenzweig; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

10.  Cellular DNA region involved in induction of thymic lymphomas (Mlvi-2) maps to mouse chromosome 15.

Authors:  P N Tsichlis; P G Strauss; C A Kozak
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.